{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:37:08Z","timestamp":1789105028874,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Medical Research Transformation Project of Anhui Province","award":["202304295107020095, 202304295107020088"],"award-info":[{"award-number":["202304295107020095, 202304295107020088"]}]},{"name":"Clinical Medical Research Transformation Project of Anhui Province","award":["202304295107020095, 202304295107020088"],"award-info":[{"award-number":["202304295107020095, 202304295107020088"]}]},{"name":"Clinical Medical Research Transformation Project of Anhui Province","award":["202304295107020095, 202304295107020088"],"award-info":[{"award-number":["202304295107020095, 202304295107020088"]}]},{"name":"Clinical Medical Research Transformation Project of Anhui Province","award":["202304295107020095, 202304295107020088"],"award-info":[{"award-number":["202304295107020095, 202304295107020088"]}]},{"name":"Clinical Medical Research Transformation Project of Anhui Province","award":["202304295107020095, 202304295107020088"],"award-info":[{"award-number":["202304295107020095, 202304295107020088"]}]},{"name":"Bozhou Key Research and Development Project","award":["bzzc2022015"],"award-info":[{"award-number":["bzzc2022015"]}]},{"name":"Bozhou Key Research and Development Project","award":["bzzc2022015"],"award-info":[{"award-number":["bzzc2022015"]}]},{"name":"Bozhou Key Research and Development Project","award":["bzzc2022015"],"award-info":[{"award-number":["bzzc2022015"]}]},{"name":"Natural Science Research Project of Anhui Educational Committee","award":["2022AH051494"],"award-info":[{"award-number":["2022AH051494"]}]},{"name":"Natural Science Research Project of Anhui Educational Committee","award":["2022AH051494"],"award-info":[{"award-number":["2022AH051494"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03653-w","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:17:30Z","timestamp":1751386650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrated network pharmacology, transcriptomics, and experimental validation to explore the mechanism of Qihuang Jianpi Zishen granules against Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1038","volume":"15","author":[{"given":"Haikun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichuang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"10","key":"3653_CR1","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/cells12101347","volume":"12","author":"P Rosso","year":"2023","unstructured":"Rosso, P. et al. Involvement of substance P (SP) and its related NK1 receptor in primary Sj\u00f6gren\u2019s syndrome (pSS) pathogenesis. Cells 12 (10), 1347. https:\/\/doi.org\/10.3390\/cells12101347 (2023).","journal-title":"Cells"},{"issue":"13","key":"3653_CR2","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.3390\/jcm12134423","volume":"12","author":"SY Nishihata","year":"2023","unstructured":"Nishihata, S. Y. et al. The toll-like receptor 7-mediated ro52 antigen-presenting pathway in the salivary gland epithelial cells of Sj\u00f6gren\u2019s syndrome. J. Clin. Med. 12 (13), 4423. https:\/\/doi.org\/10.3390\/jcm12134423 (2023).","journal-title":"J. Clin. Med."},{"issue":"19","key":"3653_CR3","doi-asserted-by":"publisher","first-page":"e38803","DOI":"10.1016\/j.heliyon.2024.e38803","volume":"10","author":"T Zhao","year":"2024","unstructured":"Zhao, T., Zhang, R., Li, Z., Qin, D. & Wang, X. Novel and potential future therapeutic options in Sj\u00f6gren\u2019s syndrome. Heliyon 10 (19), e38803. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38803 (2024).","journal-title":"Heliyon"},{"issue":"6","key":"3653_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/s41591-024-03009-3","volume":"30","author":"EW St Clair","year":"2024","unstructured":"St Clair, E. W. et al. CD40 ligand antagonist Dazodalibep in Sj\u00f6gren\u2019s disease: A randomized, double-blinded, placebo-controlled, phase 2 trial. Nat. Med. 30 (6), 1583\u20131592. https:\/\/doi.org\/10.1038\/s41591-024-03009-3 (2024).","journal-title":"Nat. Med."},{"issue":"4","key":"3653_CR5","doi-asserted-by":"publisher","first-page":"e1228","DOI":"10.1002\/ctm2.1228","volume":"13","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. Targeting alarmin release reverses Sjogren\u2019s syndrome phenotype by revitalizing Ca2\u2009+\u2009signalling. Clin. Transl Med. 13 (4), e1228. https:\/\/doi.org\/10.1002\/ctm2.1228 (2023).","journal-title":"Clin. Transl Med."},{"issue":"11","key":"3653_CR6","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin, B. et al. Epidemiology of primary Sj\u00f6gren\u2019s syndrome: A systematic review and meta-analysis. Ann. Rheum. Dis. 74 (11), 1983\u20131989. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205375 (2015).","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"3653_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","volume":"20","author":"C Baldini","year":"2024","unstructured":"Baldini, C., Fulvio, G., La Rocca, G. & Ferro, F. Update on the pathophysiology and treatment of primary Sj\u00f6gren syndrome. Nat. Rev. Rheumatol. 20 (8), 473\u2013491. https:\/\/doi.org\/10.1038\/s41584-024-01135-3 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"3653_CR8","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1038\/s41401-024-01288-7","volume":"45","author":"YQ Yang","year":"2024","unstructured":"Yang, Y. Q. et al. Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sj\u00f6gren\u2019s syndrome in mice by promoting TEC kinase degradation. Acta Pharmacol. Sin. 45 (9), 1926\u20131936. https:\/\/doi.org\/10.1038\/s41401-024-01288-7 (2024).","journal-title":"Acta Pharmacol. Sin"},{"issue":"3","key":"3653_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7150\/ijms.17718","volume":"14","author":"T Both","year":"2017","unstructured":"Both, T., Dalm, V. A. S. H., van Hagen, P. M. & van Daele, P. L. A. Reviewing primary Sj\u00f6gren\u2019s syndrome: beyond the dryness - from pathophysiology to diagnosis and treatment. Int. J. Med. Sci. 14 (3), 191\u2013200. https:\/\/doi.org\/10.7150\/ijms.17718 (2017).","journal-title":"Int. J. Med. Sci."},{"issue":"19","key":"3653_CR10","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1097\/CM9.0000000000002539","volume":"136","author":"M Li","year":"2023","unstructured":"Li, M. et al. Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sj\u00f6gren\u2019s syndrome. Chin. Med. J. 136 (19), 2297\u20132306. https:\/\/doi.org\/10.1097\/CM9.0000000000002539 (2023).","journal-title":"Chin. Med. J."},{"issue":"6","key":"3653_CR11","first-page":"1627","volume":"35","author":"S Shang","year":"2022","unstructured":"Shang, S., Li, M., Jiang, H. & Huang, C. The protective effects of Qihuang Jianpi Zishen Decoction on Mrl\/lpr mice and its mechanism. Pak J. Pharm. Sci. 35 (6), 1627\u20131635 (2022).","journal-title":"Pak J. Pharm. Sci."},{"issue":"4","key":"3653_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.20002\/j.issn.1000-7156.2022.04.008","volume":"38","author":"Y Ge","year":"2022","unstructured":"Ge, Y., Huang, C., Cheng, Y. & Xu, C. Clinical observation of Qihuang Jianpi Zishen granules as adjuvant treatment for spleen-kidney deficiency type Ii lupus nephritis. Shanxi J. Tradit Chin. Med. 38 (4), 22\u201325. https:\/\/doi.org\/10.20002\/j.issn.1000-7156.2022.04.008 (2022).","journal-title":"Shanxi J. Tradit Chin. Med."},{"issue":"22","key":"3653_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.13422\/j.cnki.syfjx.20240891","volume":"29","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Clincial efficacy of Qihuang Jianpi Zishen granules in treating cardiac involvement in systemic lupus erythematosus. Chin. J. Exp. Tradit Med. Form. 29 (22), 104\u2013111. https:\/\/doi.org\/10.13422\/j.cnki.syfjx.20240891 (2023).","journal-title":"Chin. J. Exp. Tradit Med. Form."},{"issue":"6","key":"3653_CR14","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3969\/j.issn.1008-0805.2024.06.30","volume":"35","author":"Y Cheng","year":"2024","unstructured":"Cheng, Y., Huang, C., Qian, A., Zhu, Y. & Pang, L. Observation of the clinical efficacy of Qihuang Jianpi Zishen granule in the treatment of rheumatoid arthritis. Lishizhen Med. Mater. Med. Res. 35 (6), 1411\u20131414. https:\/\/doi.org\/10.3969\/j.issn.1008-0805.2024.06.30 (2024).","journal-title":"Lishizhen Med. Mater. Med. Res."},{"issue":"12","key":"3653_CR15","first-page":"7535","volume":"37","author":"Z Tang","year":"2022","unstructured":"Tang, Z. et al. Clinical efficacy of Qihuang Jianpi Zishen granules on ankylosing spondylitis with spleen and kidney deficiency type and its effects on serum inflammatory factors. Chin. J. Tradit Chin. Med. Form. Phar. 37 (12), 7535\u20137539 (2022).","journal-title":"Chin. J. Tradit Chin. Med. Form. Phar"},{"issue":"4","key":"3653_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3969\/j.issn.2095-7246.2021.04.011","volume":"40","author":"Z Tang","year":"2021","unstructured":"Tang, Z., Huang, C., Cheng, Y. & Li, S. Clinical effect of Qihuang Jianpi Zishen granule on Sj\u00f6gren\u2019s syndrome with deficiency of both Qi and Yin. J. Anhui Univer Chin. Med. 40 (4), 41\u201345. https:\/\/doi.org\/10.3969\/j.issn.2095-7246.2021.04.011 (2021).","journal-title":"J. Anhui Univer Chin. Med."},{"issue":"13","key":"3653_CR17","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.3969\/j.issn.1008-0805.2024.13.15","volume":"35","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y., Huang, C., Qian, A. & Cheng, Y. Clinical observation of Qi Huang Jian Pi Zi Shen granules in the treatment of patients with spleen-kidney deficiency type Sj\u00f6gren\u2019s syndrome. Lishizhen Med. Mater. Med. Res. 35 (13), 3005\u20133008. https:\/\/doi.org\/10.3969\/j.issn.1008-0805.2024.13.15 (2024).","journal-title":"Lishizhen Med. Mater. Med. Res."},{"issue":"6","key":"3653_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","volume":"17","author":"GM Verstappen","year":"2021","unstructured":"Verstappen, G. M., Pringle, S., Bootsma, H. & Kroese, F. G. M. Epithelial-immune cell interplay in primary Sj\u00f6gren syndrome salivary gland pathogenesis. Nat. Rev. Rheumatol. 17 (6), 333\u2013348. https:\/\/doi.org\/10.1038\/s41584-021-00605-2 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"3653_CR19","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/art.39204","volume":"67","author":"JC Hall","year":"2015","unstructured":"Hall, J. C. et al. Molecular subsetting of interferon pathways in Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 67 (9), 2437\u20132446. https:\/\/doi.org\/10.1002\/art.39204 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"3653_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn, J. R. & Wilson, C. B. Regulation of interferon-\u03b3 during innate and adaptive immune responses. Adv. Immunol. 96, 41\u2013101. https:\/\/doi.org\/10.1016\/S0065-2776(07)96002-2 (2007).","journal-title":"Adv. Immunol."},{"issue":"11","key":"3653_CR21","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/biom10111539","volume":"10","author":"WDJ R\u00edos-R\u00edos","year":"2020","unstructured":"R\u00edos-R\u00edos, W. D. J., Sosa-Luis, S. A. & Torres-Aguilar, H. T cells subsets in the immunopathology and treatment of Sjogren\u2019s syndrome. Biomolecules 10 (11), 1539. https:\/\/doi.org\/10.3390\/biom10111539 (2020).","journal-title":"Biomolecules"},{"issue":"2","key":"3653_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder, K., Hertzog, P. J., Ravasi, T. & Hume, D. A. Interferon-\u03b3: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75 (2), 163\u2013189. https:\/\/doi.org\/10.1189\/jlb.0603252 (2004).","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"3653_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/JCMA.0000000000000884","volume":"86","author":"L Xiao","year":"2023","unstructured":"Xiao, L., Xiao, W. & Zhan, F. Targets of total glucosides of Paeony in the treatment of Sjogren syndrome: A network Pharmacology study. J. Chin. Med. Assoc. 86 (4), 375\u2013380. https:\/\/doi.org\/10.1097\/JCMA.0000000000000884 (2023).","journal-title":"J. Chin. Med. Assoc."},{"issue":"10","key":"3653_CR24","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.26355\/eurrev_202405_36287","volume":"28","author":"YY Cui","year":"2024","unstructured":"Cui, Y. Y. et al. Efficacy and safety of total glucosides of Paeony in treating primary Sj\u00f6gren\u2019s syndrome: A propensity-matched study. Eur. Rev. Med. Pharmacol. Sci. 28 (10), 3523\u20133531. https:\/\/doi.org\/10.26355\/eurrev_202405_36287 (2024).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"12","key":"3653_CR25","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.55563\/clinexprheumatol\/7kbuok","volume":"41","author":"T Jiang","year":"2023","unstructured":"Jiang, T. et al. Total glucosides of Paeony alleviates experimental Sj\u00f6gren\u2019s syndrome through inhibiting NLRP3 inflammasome activation of submandibular gland cells. Clin. Exp. Rheumatol. 41 (12), 2502\u20132510. https:\/\/doi.org\/10.55563\/clinexprheumatol\/7kbuok (2023).","journal-title":"Clin. Exp. Rheumatol."},{"key":"3653_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","volume":"127","author":"Y Tang","year":"2015","unstructured":"Tang, Y., Li, M., Wang, J., Pan, Y. & Wu, F. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems 127, 67\u201372. https:\/\/doi.org\/10.1016\/j.biosystems.2014.11.005 (2015).","journal-title":"Biosystems"},{"issue":"1","key":"3653_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrg2918","volume":"12","author":"AL Barab\u00e1si","year":"2011","unstructured":"Barab\u00e1si, A. L., Gulbahce, N. & Loscalzo, J. Network medicine: A network-based approach to human disease. Nat. Rev. Genet. 12 (1), 56\u201368. https:\/\/doi.org\/10.1038\/nrg2918 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"3653_CR28","doi-asserted-by":"publisher","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1). https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025). D672-D677.","DOI":"10.1093\/nar\/gkae909"},{"issue":"11","key":"3653_CR29","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"3653_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"3653_CR31","doi-asserted-by":"publisher","first-page":"117792","DOI":"10.1016\/j.jep.2024.117792","volume":"324","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Network pharmacology, molecular docking, and in vitro experimental verification of the mechanism of Guanxining in treating diabetic atherosclerosis. J. Ethnopharmacol. 324, 117792. https:\/\/doi.org\/10.1016\/j.jep.2024.117792 (2024).","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"3653_CR32","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s12013-024-01337-2","volume":"82","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q., Yang, X. R. & Deng, Y. Iguratimod alleviates experimental Sj\u00f6gren\u2019s syndrome by inhibiting NLRP3 inflammasome activation. Cell. Biochem. Biophys. 82 (3), 2275\u20132283. https:\/\/doi.org\/10.1007\/s12013-024-01337-2 (2024).","journal-title":"Cell. Biochem. Biophys."},{"issue":"1","key":"3653_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/icb.2008.70","volume":"87","author":"M Bulosan","year":"2009","unstructured":"Bulosan, M. et al. Inflammatory caspases are critical for enhanced cell death in the target tissue of Sj\u00f6gren\u2019s syndrome prior to disease onset. Immunol. Cell. Biol. 87 (1), 81\u201390. https:\/\/doi.org\/10.1038\/icb.2008.70 (2009).","journal-title":"Immunol. Cell. Biol."},{"key":"3653_CR34","unstructured":"Niu, R. J. Study on the suppressive of Ginsenoside Rh1 on the inflammation and apoptosis of human salivary gland cells induced by interferon-\u03b3. Jilin University, Jilin, China. (2022). https:\/\/link.cnki.net\/doi\/10.27162\/d.cnki.gjlin.2022.005677"},{"issue":"1","key":"3653_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cardiores.2007.06.003","volume":"76","author":"NA Turner","year":"2007","unstructured":"Turner, N. A. et al. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of Statins and Thiazolidinediones. Cardiovasc. Res. 76 (1), 81\u201390. https:\/\/doi.org\/10.1016\/j.cardiores.2007.06.003 (2007).","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"3653_CR36","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.7150\/ijms.83801","volume":"20","author":"J Xu","year":"2023","unstructured":"Xu, J. et al. Lactate-induced MtDNA accumulation activates cGAS-STING signaling and the inflammatory response in Sj\u00f6gren\u2019s syndrome. Int. J. Med. Sci. 20 (10), 1256\u20131271. https:\/\/doi.org\/10.7150\/ijms.83801 (2023).","journal-title":"Int. J. Med. Sci."},{"key":"3653_CR37","doi-asserted-by":"publisher","unstructured":"Tian, Y., Yang, H., Liu, N., Li, Y. & Chen, J. Advances in pathogenesis of sj\u00f6gren\u2019s syndrome. J. Immunol. Res. 2021 (5928232). https:\/\/doi.org\/10.1155\/2021\/5928232 (2021).","DOI":"10.1155\/2021\/5928232"},{"issue":"5","key":"3653_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41584-023-00932-6","volume":"19","author":"GE Thorlacius","year":"2023","unstructured":"Thorlacius, G. E., Bj\u00f6rk, A. & Wahren-Herlenius, M. Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies. Nat. Rev. Rheumatol. 19 (5), 288\u2013306. https:\/\/doi.org\/10.1038\/s41584-023-00932-6 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"3653_CR39","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0254-6272(15)30064-9","volume":"34","author":"F Wang","year":"2014","unstructured":"Wang, F. et al. Astragalus polysaccharides improved the cardiac function in Sj\u00f6gren\u2019s syndrome model rats based on Keap 1-Nrf2\/ARE signaling pathway: a mechanism exploration. Chin. J. Inter Tradit West. Med. 34 (5), 566\u2013574 (2014).","journal-title":"Chin. J. Inter Tradit West. Med."},{"key":"3653_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-024-04491-5","author":"Y Liang","year":"2024","unstructured":"Liang, Y. et al. H(2)O(2)-challenged KGN human granulosa cell line. BMC Complement. Med. Ther. 24 (1), 189. https:\/\/doi.org\/10.1186\/s12906-024-04491-5 (2024). Wine- and stir-frying processing of Cuscutae Semen enhance its ability to alleviate oxidative stress and apoptosis via the Keap 1-Nrf2\/HO-1 and PI3K\/AKT pathways."},{"issue":"1","key":"3653_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13020-020-00342-w","volume":"15","author":"WW Lu","year":"2020","unstructured":"Lu, W. W. et al. The effect of total glucoside of Paeony on gut microbiota in NOD mice with Sj\u00f6gren\u2019s syndrome based on high-throughput sequencing of 16SrRNA gene. Chin. Med. 15 (1), 61. https:\/\/doi.org\/10.1186\/s13020-020-00342-w (2020).","journal-title":"Chin. Med."},{"issue":"6","key":"3653_CR42","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/ddr.21964","volume":"83","author":"L Chang","year":"2022","unstructured":"Chang, L. et al. Quercetin ameliorates salivary gland apoptosis and inflammation in primary Sj\u00f6gren\u2019s syndrome through regulation of the leptin\/OB-R signaling. Drug Dev. Res. 83 (6), 1351\u20131361. https:\/\/doi.org\/10.1002\/ddr.21964 (2022).","journal-title":"Drug Dev. Res."},{"issue":"6","key":"3653_CR43","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.2174\/1386207325666220823144054","volume":"26","author":"F Wu","year":"2023","unstructured":"Wu, F. et al. Exploring the target and mechanism of radix paeoniae Alba on Sjogren\u2019s syndrome. Comb. Chem. High. Throughput Screen. 26 (6), 1224\u20131232. https:\/\/doi.org\/10.2174\/1386207325666220823144054 (2023).","journal-title":"Comb. Chem. High. Throughput Screen."},{"issue":"7","key":"3653_CR44","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/ard.2010.138966","volume":"70","author":"S Appel","year":"2011","unstructured":"Appel, S. et al. Potential association of muscarinic receptor 3 gene variants with primary Sjogren\u2019s syndrome. Ann. Rheum. Dis. 70 (7), 1327\u20131329. https:\/\/doi.org\/10.1136\/ard.2010.138966 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"3653_CR45","doi-asserted-by":"publisher","first-page":"155412","DOI":"10.1016\/j.phymed.2024.155412","volume":"128","author":"HT Xu","year":"2024","unstructured":"Xu, H. T. et al. Formononetin attenuates psoriasiform inflammation by regulating interferon signaling pathway. Phytomedicine 128, 155412. https:\/\/doi.org\/10.1016\/j.phymed.2024.155412 (2024).","journal-title":"Phytomedicine"},{"key":"3653_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuro.2021.05.014","volume":"85","author":"M Sugimoto","year":"2021","unstructured":"Sugimoto, M. et al. Formononetin attenuates H2O2-induced cell death through decreasing ROS level by PI3K\/akt-Nrf2-activated antioxidant gene expression and suppressing MAPK-regulated apoptosis in neuronal SH-SY5Y cells. Neurotoxicology 85, 186\u2013200. https:\/\/doi.org\/10.1016\/j.neuro.2021.05.014 (2021).","journal-title":"Neurotoxicology"},{"issue":"Pt 1","key":"3653_CR47","doi-asserted-by":"publisher","first-page":"113357","DOI":"10.1016\/j.intimp.2024.113357","volume":"143","author":"X He","year":"2024","unstructured":"He, X. et al. Study of Kaempferol in the treatment of rheumatoid arthritis through modulation of the NLRP3\/CASP1\/GSDMD axis and T-cell activation: based on network pharmacology, single-cell analysis, and experimental validation. Int. Immunopharmacol. 143 (Pt 1), 113357. https:\/\/doi.org\/10.1016\/j.intimp.2024.113357 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"3653_CR48","doi-asserted-by":"publisher","first-page":"106878","DOI":"10.1016\/j.intimp.2020.106878","volume":"88","author":"C Chen","year":"2020","unstructured":"Chen, C., Liang, Y., Zhang, Z., Zhang, Z. & Yang, Z. Relationships between increased Circulating YKL-40, IL-6 and TNF-\u03b1 levels and phenotypes and disease activity of primary Sj\u00f6gren\u2019s syndrome. Int. Immunopharmacol. 88, 106878. https:\/\/doi.org\/10.1016\/j.intimp.2020.106878 (2020).","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"3653_CR49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2174\/1871530321666210809155147","volume":"22","author":"S Benchabane","year":"2022","unstructured":"Benchabane, S. et al. Association between increased bcl-2, Fas and FasL levels and inflammation extent in labial salivary glands during primary Sj\u00f6gren\u2019s syndrome. Endocr. Metab. Immune Disord Drug Targets. 22 (3), 328\u2013338. https:\/\/doi.org\/10.2174\/1871530321666210809155147 (2022).","journal-title":"Endocr. Metab. Immune Disord Drug Targets"},{"issue":"6","key":"3653_CR50","first-page":"970","volume":"29","author":"EH Kang","year":"2011","unstructured":"Kang, E. H., Lee, Y. J., Hyon, J. Y., Yun, P. Y. & Song, Y. W. Salivary cytokine profiles in primary Sj\u00f6gren\u2019s syndrome differ from those in non-sj\u00f6gren Sicca in terms of TNF-\u03b1 levels and th-1\/th-2 ratios. Clin. Exp. Rheumatol. 29 (6), 970\u2013976 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"key":"3653_CR51","doi-asserted-by":"publisher","unstructured":"Xu, X. et al. Decoding the mechanism of CheReCunJin formula in treating sj\u00f6gren\u2019s syndrome based on network pharmacology and molecular docking. Evid. Based Complement. Alternat. Med. 1193846. (2022). https:\/\/doi.org\/10.1155\/2022\/1193846 (2022).","DOI":"10.1155\/2022\/1193846"},{"issue":"1","key":"3653_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/sarh.2003.50019","volume":"33","author":"P Manganelli","year":"2003","unstructured":"Manganelli, P. & Fietta, P. Apoptosis and Sj\u00f6gren syndrome. Semin Arthritis Rheum. 33 (1), 49\u201365. https:\/\/doi.org\/10.1053\/sarh.2003.50019 (2003).","journal-title":"Semin Arthritis Rheum."},{"issue":"1","key":"3653_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11626-019-00409-5","volume":"56","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. MiR-let-7d-3p regulates IL-17 expression through targeting AKT1\/mTOR signaling in CD4\u2009+\u2009T cells. Vitro Cell. Dev. Biol. Anim. 56 (1), 67\u201374. https:\/\/doi.org\/10.1007\/s11626-019-00409-5 (2020).","journal-title":"Vitro Cell. Dev. Biol. Anim."},{"key":"3653_CR54","doi-asserted-by":"publisher","first-page":"719958","DOI":"10.3389\/fmed.2021.719958","volume":"8","author":"J Cui","year":"2022","unstructured":"Cui, J. et al. Novel immune-related genetic expression for primary Sj\u00f6gren\u2019s syndrome. Front. Med. 8, 719958. https:\/\/doi.org\/10.3389\/fmed.2021.719958 (2022).","journal-title":"Front. Med."},{"key":"3653_CR55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2016.08.035","volume":"101","author":"E Varfolomeev","year":"2018","unstructured":"Varfolomeev, E. & Vucic, D. Intracellular regulation of TNF activity in health and disease. Cytokine 101, 26\u201332. https:\/\/doi.org\/10.1016\/j.cyto.2016.08.035 (2018).","journal-title":"Cytokine"},{"issue":"11","key":"3653_CR56","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/intimm\/dxr077","volume":"23","author":"T Mori","year":"2011","unstructured":"Mori, T. et al. IL-1\u03b2 and TNF\u03b1-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. Int. Immunol. 23 (11), 701\u2013712. https:\/\/doi.org\/10.1093\/intimm\/dxr077 (2011).","journal-title":"Int. Immunol."},{"issue":"3","key":"3653_CR57","doi-asserted-by":"publisher","first-page":"e92363","DOI":"10.1371\/journal.pone.0092363","volume":"9","author":"JS Otis","year":"2014","unstructured":"Otis, J. S. et al. Pro-inflammatory mediation of myoblast proliferation. PloS One. 9 (3), e92363. https:\/\/doi.org\/10.1371\/journal.pone.0092363 (2014).","journal-title":"PloS One"},{"issue":"5","key":"3653_CR58","doi-asserted-by":"publisher","first-page":"R1249","DOI":"10.1152\/ajpregu.00490.2002","volume":"284","author":"G Luo","year":"2003","unstructured":"Luo, G., Hershko, D. D., Robb, B. W., Wray, C. J. & Hasselgren, P. O. IL-1beta stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-kappa B. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (5), R1249\u20131254. https:\/\/doi.org\/10.1152\/ajpregu.00490.2002 (2003).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"3653_CR59","doi-asserted-by":"publisher","first-page":"115210","DOI":"10.1016\/j.biopha.2023.115210","volume":"165","author":"L Ji","year":"2023","unstructured":"Ji, L. et al. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network Pharmacology and experimental validation. Biomed. Pharmacother. 165, 115210. https:\/\/doi.org\/10.1016\/j.biopha.2023.115210 (2023).","journal-title":"Biomed. Pharmacother"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03653-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03653-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03653-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:17:37Z","timestamp":1751386657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03653-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3653"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03653-w","relation":{"references":[{"id-type":"doi","id":"10.1186\/s12906-024-04491-5","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21176"}}